Addex Therapeutics Ltd (ADXN), a clinical-stage biopharmaceutical company specializing in innovative treatments for neurological disorders, is set to release its official Q3 2024 financial results on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results